Arcutis Biotherapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ARQT Nasdaq 2830 www.arcutis.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics: Zoryve foam treatment resulted in major improvements - May 8th, 2025 3:26 pm
Arcutis Biotherapeutics First Quarter 2025 Earnings: Beats Expectations - May 8th, 2025 12:36 pm
Q1 2025 Arcutis Biotherapeutics Inc Earnings Call - May 7th, 2025 3:47 pm
Arcutis Announces Publication of Positive Data from ARRECTOR Trial Evaluating ZORYVE® (roflumilast) Foam 0.3% in Individuals with Psoriasis in Journal of American Medical Association Dermatology - May 7th, 2025 3:18 pm
Arcutis Biotherapeutics Inc (ARQT) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ... - May 7th, 2025 7:21 am
Arcutis Biotherapeutics, Inc. (ARQT) Reports Q1 Loss, Tops Revenue Estimates - May 6th, 2025 9:10 pm
Arcutis Announces First Quarter 2025 Financial Results and Provides Business Update - May 6th, 2025 8:00 pm
Exploring High Growth Tech Stocks In The US Market - May 6th, 2025 11:38 am
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 2nd, 2025 8:00 pm
Qiagen (QGEN) Reports Next Week: Wall Street Expects Earnings Growth - Apr 30th, 2025 2:01 pm
Arcutis Biotherapeutics, Inc. (ARQT) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Apr 29th, 2025 2:01 pm
Is Arcutis Biotherapeutics (ARQT) Stock Outpacing Its Medical Peers This Year? - Apr 24th, 2025 1:40 pm
Arcutis to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025 - Apr 17th, 2025 12:00 pm
Arcutis Announces Chief Financial Officer Transition - Apr 10th, 2025 8:30 pm
Arcutis Biotherapeutics (ARQT) Moves 10.8% Higher: Will This Strength Last? - Apr 3rd, 2025 2:01 pm
Why Arcutis Biotherapeutics Inc. (ARQT) Went Up On Wednesday? - Apr 3rd, 2025 8:47 am
Sector Update: Health Care Stocks Advance in Late Afternoon Trading - Apr 2nd, 2025 7:59 pm
Arcutis and Padagis Agree to Stay Patent Lawsuit - Apr 2nd, 2025 5:16 pm
Why IBD 50's Arcutis Is Outplaying The Biotech Tape And Just Reentered Its Buy Zone - Mar 28th, 2025 8:15 pm
How Much Upside is Left in Arcutis Biotherapeutics (ARQT)? Wall Street Analysts Think 25.85% - Mar 28th, 2025 1:55 pm